Cancer-Focused Nano-Cap Is Surging- Here’s Why

Vandana Singh | July 11, 2024

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) announced progress on eRapa, its drug to treat Familial Adenomatous Polyposis (FAP), an inherited disorder characterized by cancer of the large intestine (colon) and rectum. 12-month data from a phase 2 clinical trial were recently presented at the 2024 InSIGHT biannual meeting. With FAP, hundreds or thousands of precancerous polyps grow throughout […]

Why Is Vanda Pharmaceuticals Stock Trading Higher Today?

Vandana Singh | April 3, 2024

Tuesday, the FDA approved Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Fanapt is an atypical antipsychotic agent that has been used for the acute treatment of patients with schizophrenia since its FDA approval in 2009. Bipolar disorder is a psychiatric chronic condition […]

Wait! Before you go...

Always be feeding your money brain. Claim one or all of the FREE offers from some of our partners below.

x